Novel strategies for the treatment of lung cancer: modulation of eicosanoids

J Clin Oncol. 2008 Feb 20;26(6):825-7. doi: 10.1200/JCO.2007.14.9583.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / metabolism*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / metabolism
  • Celecoxib
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Eicosanoids / antagonists & inhibitors*
  • Eicosanoids / metabolism
  • Gene Expression Regulation, Enzymologic / drug effects
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Hydroxyurea / analogs & derivatives*
  • Hydroxyurea / therapeutic use
  • Lipoxygenase Inhibitors / therapeutic use*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / metabolism
  • Pyrazoles / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Sulfonamides / therapeutic use*
  • Up-Regulation

Substances

  • Biomarkers, Tumor
  • Cyclooxygenase 2 Inhibitors
  • Eicosanoids
  • Lipoxygenase Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Cyclooxygenase 2
  • Celecoxib
  • zileuton
  • Hydroxyurea